Literature DB >> 12874297

Antibody-mediated immunity against intracellular pathogens: two-dimensional thinking comes full circle.

Arturo Casadevall1.   

Abstract

Mesh:

Substances:

Year:  2003        PMID: 12874297      PMCID: PMC166024          DOI: 10.1128/IAI.71.8.4225-4228.2003

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


× No keyword cloud information.
  49 in total

Review 1.  Antibody-mediated protection against intracellular pathogens.

Authors:  A Casadevall
Journal:  Trends Microbiol       Date:  1998-03       Impact factor: 17.079

2.  Anti-Ehrlichia chaffeensis antibody complexed with E. chaffeensis induces potent proinflammatory cytokine mRNA expression in human monocytes through sustained reduction of IkappaB-alpha and activation of NF-kappaB.

Authors:  E H Lee; Y Rikihisa
Journal:  Infect Immun       Date:  1997-07       Impact factor: 3.441

3.  Effect of immunoglobulin G isotype on the infectivity of Chlamydia trachomatis in a mouse model of intravaginal infection.

Authors:  E M Peterson; X Cheng; V L Motin; L M de la Maza
Journal:  Infect Immun       Date:  1997-07       Impact factor: 3.441

4.  Monoclonal immunoglobulin A antibody to the major outer membrane protein of the Chlamydia trachomatis mouse pneumonitis biovar protects mice against a chlamydial genital challenge.

Authors:  S Pal; I Theodor; E M Peterson; L M de la Maza
Journal:  Vaccine       Date:  1997-04       Impact factor: 3.641

5.  Effect of serum IgG1 to Cryptococcus neoformans glucuronoxylomannan on murine pulmonary infection.

Authors:  M Feldmesser; A Casadevall
Journal:  J Immunol       Date:  1997-01-15       Impact factor: 5.422

6.  T cells cooperate with passive antibody to modify Cryptococcus neoformans infection in mice.

Authors:  R R Yuan; A Casadevall; J Oh; M D Scharff
Journal:  Proc Natl Acad Sci U S A       Date:  1997-03-18       Impact factor: 11.205

7.  Humoral immunity and regulation of intrapulmonary growth of Legionella pneumophila in the immunocompetent host.

Authors:  J K Brieland; L A Heath; G B Huffnagle; D G Remick; M S McClain; M C Hurley; R K Kunkel; J C Fantone; C Engleberg
Journal:  J Immunol       Date:  1996-12-01       Impact factor: 5.422

8.  Antibody-mediated protection against Brucella abortus in BALB/c mice at successive periods after infection: variation between virulent strain 2308 and attenuated vaccine strain 19.

Authors:  P H Elzer; R H Jacobson; S M Jones; K H Nielsen; J T Douglas; A J Winter
Journal:  Immunology       Date:  1994-08       Impact factor: 7.397

9.  Antibody response that protects against disseminated candidiasis.

Authors:  Y Han; J E Cutler
Journal:  Infect Immun       Date:  1995-07       Impact factor: 3.441

Review 10.  Serum therapy for tuberculosis revisited: reappraisal of the role of antibody-mediated immunity against Mycobacterium tuberculosis.

Authors:  A Glatman-Freedman; A Casadevall
Journal:  Clin Microbiol Rev       Date:  1998-07       Impact factor: 26.132

View more
  39 in total

1.  Characterization of Francisella tularensis outer membrane proteins.

Authors:  Jason F Huntley; Patrick G Conley; Kayla E Hagman; Michael V Norgard
Journal:  J Bacteriol       Date:  2006-11-17       Impact factor: 3.490

Review 2.  Antibody-mediated immunomodulation: a strategy to improve host responses against microbial antigens.

Authors:  L Jeannine Brady
Journal:  Infect Immun       Date:  2005-02       Impact factor: 3.441

Review 3.  New concepts in antibody-mediated immunity.

Authors:  Arturo Casadevall; Liise-anne Pirofski
Journal:  Infect Immun       Date:  2004-11       Impact factor: 3.441

Review 4.  The role of B cells and humoral immunity in Mycobacterium tuberculosis infection.

Authors:  John Chan; Simren Mehta; Sushma Bharrhan; Yong Chen; Jacqueline M Achkar; Arturo Casadevall; JoAnne Flynn
Journal:  Semin Immunol       Date:  2014-10-28       Impact factor: 11.130

5.  A therapeutic anti-Streptococcus mutans monoclonal antibody used in human passive protection trials influences the adaptive immune response.

Authors:  Rebekah A Robinette; Monika W Oli; William P McArthur; L Jeannine Brady
Journal:  Vaccine       Date:  2011-06-23       Impact factor: 3.641

Review 6.  Infectious Complications of Biological and Small Molecule Targeted Immunomodulatory Therapies.

Authors:  Joshua S Davis; David Ferreira; Emma Paige; Craig Gedye; Michael Boyle
Journal:  Clin Microbiol Rev       Date:  2020-06-10       Impact factor: 26.132

Review 7.  Antibody-mediated immunity against tuberculosis: implications for vaccine development.

Authors:  Jacqueline M Achkar; Arturo Casadevall
Journal:  Cell Host Microbe       Date:  2013-03-13       Impact factor: 21.023

8.  Correlation between bioluminescence and bacterial burden in passively protected mice challenged with a recombinant bioluminescent M49 group A streptococcus Strain.

Authors:  Meru Sheel; Manisha Pandey; Michael F Good; Michael R Batzloff
Journal:  Clin Vaccine Immunol       Date:  2009-11-04

9.  Yersinia pestis can bypass protective antibodies to LcrV and activation with gamma interferon to survive and induce apoptosis in murine macrophages.

Authors:  Betty L Noel; Sarit Lilo; Daniel Capurso; Jim Hill; James B Bliska
Journal:  Clin Vaccine Immunol       Date:  2009-08-26

Review 10.  IgM in microbial infections: taken for granted?

Authors:  Rachael Racine; Gary M Winslow
Journal:  Immunol Lett       Date:  2009-06-17       Impact factor: 3.685

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.